Statins lower plasma cholesterol by upregulating LDL receptor gene expression and are consequently relatively ineffective in homozygous familial hypercholesterolemia (HoFH). The standard treatment ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, Marketbeat ...

Saccharina japonica, one of the most widely cultivated seaweeds globally, is particularly prominent along China's coastline, ...

LIB Therapeutics announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA ...

In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in the second quarter of 2025, with final dose ...

Bryce is a senior journalist with Australian Community Media's Stock & Land where he reports on all aspects of agriculture.

New York State Common Retirement Fund reduced its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The fund owned ...

A longtime vendor of the Charnelle Charolais Female and Genetics Sale nabbed the top result of the 15th annual auction in ...

The following is a summary of “GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis,” published in the February 2025 ...